Post ASH 2022: Acute Myeloid Leukemia

Review Article

Haema 2023; 14(1-4):6-10

Michael D. Diamantidis1, George Vassilopoulos2

1Thalassemia and Sickle Cell Disease Unit, Department of Hematology, General Hospital of Larissa, Larissa, Greece
2University of Thessaly Medical School, Head, Division of Hematology, Larisa University Hospital, Affiliate Investigator, Cell and Gene Therapy Lab, BRFAA Athens, Greece

 

Full PDF |

Continue reading “Post ASH 2022: Acute Myeloid Leukemia”

Post ASH 2022: Acute Myeloid Leukemia

Review Article

Haema 2023; 14(1-4):6-10

Michael D. Diamantidis1, George Vassilopoulos2

1Thalassemia and Sickle Cell Disease Unit, Department of Hematology, General Hospital of Larissa, Larissa, Greece,
2University of Thessaly Medical School, Head, Division of Hematology, Larisa University Hospital, Affiliate Investigator, Cell and Gene Therapy Lab, BRFAA Athens, Greece

 

Full PDF |

Continue reading “Post ASH 2022: Acute Myeloid Leukemia”